Apellis Pharmaceuticals, Inc. announced it raised $20 Million in an initial filing from an offering of $60.1 Million

Aug 17, 2017•almost 8 years ago

Amount Raised

$20 Million

WalthamBiopharmaTherapeuticsPharmaceuticalBiotechnologyHealth Care

Company Information

Company

Apellis Pharmaceuticals, Inc.

Location

6400 WESTWIND WAY

Waltham, Massachusetts, United States

About

Apellis Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of various diseases, including geographic atrophy (GA) and other retinal diseases. The company is focused on delivering life-changing treatments for patients with serious diseases.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Apellis Pharmaceuticals, Inc. announced it raised $20 Million in an initial filing from an offering of $60.1 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information